• 1
    Bernasconi E, Jost J, Ledergerber B, Hirschel B, Francioli P, Sudre P. Antiretroviral prophylaxis for community exposure to human immunodeficiency virus in Switzerland, 1997–2000. Swiss Med Wkly 2001; 131: 433437.
  • 2
    Laporte A, Nathalie J, Elisabeth B, Lamontagne F, Pillonel J, Desenclos JC. Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians' experiences and attitudes. AIDS 2002; 16: 397405.
  • 3
    Rey D, Bendiane MK, Moatti JP, Wellings K, Danziger R, MacDowall W. Post-exposure prophylaxis after occupational and non-occupational exposures to HIV: an overview of the policies implemented in 27 European countries. The European Study Group on HIV Testing Policies and Practices in Europe. AIDS Care 2000; 12: 695701.
  • 4
    Correll PK, Smith DE, Grulich AE. Post exposure prophylaxis for non-occupational exposure to HIV. Experience in New South Wales one year after the guidelines. NSW Public Health Bull 2000; 11: 114117.
  • 5
    Centers for Disease Control and Prevention. Antiretroviral post exposure prophylaxis after sexual, injection-drug use or other nonoccupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. Morbidity and Mortality Weekly Report 2005; 54: 119.
  • 6
    Almeda J, Casabona J, Simon B et al. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe. Euro Surveill 2004; 9: 3540.
  • 7
    Roland M. HIV Post-Exposure Prophylaxis Following Non-Occupational Exposures. Background paper for WHO consultation, 3–5 September 2005. 2006.
  • 8
    Centres for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for post-exposure prophylaxis. Morbidity and Mortality Weekly Report 2001; 50: 152.
  • 9
    Katz MH, Gerberding JL. Post-exposure prophylaxis after sexual exposure to HIV. J HIV Ther 2000; 5: 59.
  • 10
    Hosseinipour M, Cohen MS, Vernazza PL, Kashuba ADM. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis 2002; 34: 13911395.
  • 11
    Australian National Council on AIDS, Hepatitis C & Related Diseases (ANCAHRD). Guidelines for the management and post exposure prophylaxis of individuals who sustain non-occupational exposure to HIV. The ANCAHRD Bulletin, Vol. 28, 2001. 2006.
  • 12
    Rawstorne P, Treloar C, Richters J. Annual Report of Behaviour 2005. HIV/AIDS, Hepatitis and Sexually Transmissible Infections in Australia. 2006.
  • 13
    Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150: 306311.
  • 14
    De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994; 331: 341346.
  • 15
    De Romero J, Marinovich B, Castilla J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 2002; 9: 12961297.
  • 16
    Henderson DK, Fahey BJ, Willy M et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med 1990; 113: 740746.
  • 17
    Hull P, Rawstorne P, Prestage G et al. Sydney Gay Community Periodic Survey August 2005. 2006.
  • 18
    Hull P, Rawstorne P, Zablotska I et al. Gay Community Periodic Survey Queensland, 2005. 2006.
  • 19
    Hull P, Prestage G, Rawstorne P et al. Gay Community Periodic Survey Melbourne, 2005. 2006.
  • 20
    Hull P, Van de Ven P, Prestage G, Kippax S, Schamburg K, Coase D. Gay Community Periodic Survey Canberra, 2003. 2006.
  • 21
    UNAIDS. UNAIDS/WHO Epidemiological Fact Sheet–2004 Update, Australia. 2006.
  • 22
    National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2005. Sydney, Australia, National Centre in HIV Epidemiology and Clinical Research, the University of New South Wales; Canberra, Australia, Australian Institute of Health and Welfare, 2005.
  • 23
    Jin FY, Prestage GP, Law MG et al. Predictors of recent HIV testing in homosexual men in Australia. HIV Med 2002; 3: 271276.
  • 24
    Grulich A, Jin FY, Poynten IM et al. Previous use of non-occupational post exposure prophylaxis against HIV (NPEP) and subsequent HIV infection in homosexual men: data from the HIM cohort. 16th International AIDS Conference. Toronto, Canada, August 2006 [Abstract TUPE 0434].
  • 25
    Kahn JO, Martin JN, Roland ME et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP study. J Infect Dis 2001; 183: 707714.
  • 26
    Greub G, Gallant S, Zurn P et al. Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person. AIDS 2002; 16: 11711176.
  • 27
    Crawford JM, Kippax SC, Mao L et al. Number of risk acts by relationship status and partner serostatus: findings from the HIM cohort of homosexually active men in Sydney, Australia. AIDS Behav 2006; 10: 325331.
  • 28
    Winston A, McAllister J, Amin J, Cooper DA, Carr A. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis. HIV Med 2005; 6: 191197.
  • 29
    Roland ME, Martin JN, Grant RM et al. Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure. J Infect Dis 2001; 184: 16081612.